Cara Therapeutics Announces Positive Phase 2 Results In Patients With Kidney Failure
July 23, 2015 at 14:08 PM EDT
Cara Therapeutics' drug CR845 is used to reducing itching for patients that have uremic pruritis. Shares are up almost 35% on the news.
